Radiology Doctors in Rocky Mount, NC Accepting Medicare
6 Radiology doctors found. Showing 1 - 6
 Dr. Linda L Willis, MD Radiology - Diagnostic Ultrasound Medicare: Not Enrolled in Medicare Practice Location: 131 Roundabout Ct, Rocky Mount, NC 27804 Phone: 252-443-4024 Fax: 252-443-5021 |
 Dr. Todd Harrison Duncan, Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 131 Roundabout Ct, Rocky Mount, NC 27804 Phone: 252-443-4024 Fax: 252-443-5021 |
Dr. Stephen H. Ladwig, MD Radiology - Diagnostic Radiology Medicare: Medicare Enrolled Practice Location: 131 Roundabout Ct, Rocky Mount, NC 27804 Phone: 252-443-4024 Fax: 252-443-0521 |
Dr. Ivan Y Peacock, MD Radiology - Diagnostic Radiology Medicare: Not Enrolled in Medicare Practice Location: 131 Roundabout Ct, Rocky Mount, NC 27804 Phone: 252-443-4024 Fax: 252-443-5021 |
Dr. Laura L Jacimore, MD Radiology - Radiation Oncology Medicare: Accepting Medicare Assignments Practice Location: 2450 Curtis Ellis Dr, Rocky Mount, NC 27804 Phone: 252-443-8947 Fax: 252-451-3090 |
Dr. Richard T Fritz, MD Radiology - Diagnostic Radiology Medicare: Not Enrolled in Medicare Practice Location: 131 Roundabout Ct, Rocky Mount, NC 27804 Phone: 252-443-4024 Fax: 252-443-5021 |
News Archive
Gene responsible for cancer growth plays unexpected role in prostate cancer
A gene that is responsible for cancer growth plays a totally unexpected role in prostate cancer. The gene Stat3 is controlled by the immune modulator interleukin 6 and normally supports the growth of cancer cells. The international research team led by Prof. Lukas Kenner from the Medical University of Vienna, the Veterinary University of Vienna, and the Ludwig Boltzmann Institiute for Cancer Research (LBI-CR) discovered a missing link for an essential role of Stat3 and IL-6 signalling in prostate cancer progression.
1 in 6 insured hospital patients get a surprise bill for out-of-network care
About 1 in 6 Americans were surprised by a medical bill after treatment in a hospital in 2017 despite having insurance, according to a study published Thursday.
Leadiant Biosciences announces FDA approval of Revcovi for treating pediatric, adult ADA-SCID patients
Leadiant Biosciences, Inc. today announced that the Food and Drug Administration has granted approval to Revcovi (elapegademase-lvlr) injection in the U.S. Revcovi is a new enzyme replacement therapy for the treatment of adenosine deaminase severe combined immune deficiency in pediatric and adult patients.
USC study shows how tumor cells circulating in the blood target distant organs
Most cancers kill because tumor cells spread beyond the primary site to invade other organs. Now, a USC study of brain-invading breast cancer cells circulating in the blood reveals they have a molecular signature indicating specific organ preferences.
› Verified 5 days ago
Internal Medicine
Family Medicine
Pediatrics
Emergency Medicine
Orthopaedic Surgery
Surgery
Psychiatry & Neurology
Obstetrics & Gynecology
Anesthesiology
Radiology